CORTEXYME, INC. EXECUTIVE CHANGE IN CONTROL AND SEVERANCE AGREEMENTControl and Severance Agreement • October 29th, 2021 • Cortexyme, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledOctober 29th, 2021 Company Industry JurisdictionThis Executive Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Ted Monohon (“Executive”) and Cortexyme, Inc. (the “Company”), effective as of September 21, 2021 (the “Effective Date”).